1. Why Does Stepping Over Lines on the Floor Help People with Parkinson’s Disease Move?
Parkinson’s disease is a condition where symptoms include difficulty starting movement and slow motion. However, under certain conditions, the same person can move at a speed close to normal. This phenomenon is called "paradoxical movement" and has been reported as a temporary overcoming of slowness when there is strong motivation or an external cue [5].
A well-known example involves lines on the floor. Parden-Marchin showed that patients with slow movement could walk at a normal speed if lines were drawn on the floor at intervals equal to their stride length. Luria recorded a patient who could only take one step at a time when paper was placed on the floor, but could climb a ladder. In 1921, Sok reported cases where patients could climb stairs [5].
There are also examples from emergencies. After the 2009 L’Aquila earthquake in Italy, 14 patients with Parkinson’s disease who were interviewed all reported that they woke up at night, evacuated their homes, and many helped others [5].
Being able to move in this way is temporary, and the disease is not cured. So, what causes the difficulty in movement? Before exploring that, let us look at the origin of the disease’s name.
2. Who First Described Parkinson’s Disease, and How Did It Get Its Name?
In 1817, London doctor James Parkinson (1755–1824) published a 66-page book titled *An Essay on the Shaking Palsy*. Based on observations of six people, he described tremors that occur even when still, a posture where the body leans forward, and a tendency for feet to shuffle while walking [2].
Parkinson wrote that in this disease, "sensation and intellect are unimpaired." However, later research showed that there are symptoms other than movement issues, so this point has been revised [2].
It is said that Charcot helped establish the name. Around the 1860s, he called it "Parkinson’s disease" and is reported to have encouraged students at the Salpêtrière Hospital to translate the paper [2].
The name of the disease is also a record of one person’s observations being read by later generations. Here, the question remains: what is decreasing inside the brain?
3. How Did Animals That Stopped Moving Give Researchers a Clue About Parkinson’s Disease?
Swedish researcher Arvid Carlsson found that giving the drug reserpine to experimental animals caused them to lose the ability to move on their own. However, when given L-DOPA, a precursor to dopamine, the animals could move again. The fact that this resembled Parkinson’s disease provided a clue [3].
Carlsson showed that dopamine is not just a material but a neurotransmitter itself—a substance that transmits signals from nerve to nerve. In 2000, he received the Nobel Prize in Physiology or Medicine, along with two others, for the discovery of signal transmission in the nervous system [3].
Oleh Hornykiewicz of the Medical University of Vienna announced in 1960 that dopamine levels in the basal ganglia of the brain were significantly reduced in patients with Parkinson’s disease [4]. This was the moment when the "immobility" seen in animal experiments was linked to changes in the human brain.
By the way, current explanations state that damage to dopamine neurons in the substantia nigra is involved in the onset of the disease, but the cause itself is not known [1].
4. How Was L-DOPA, a Drug That Adds the Missing Dopamine, Developed?
If dopamine is decreasing in the brain, adding it should help. In 1961, Hornykiewicz, together with Birkmayer, demonstrated the therapeutic effect of L-DOPA [4]. L-DOPA is still considered a central drug in the treatment of Parkinson’s disease [3].
However, this treatment alleviates symptoms and does not eliminate the disease itself. According to the National Center for Global Health and Medicine (NCGM), the cause is currently unknown, though it is known that genetic abnormalities and environmental factors are involved. A radical cure has not been established, and all treatments are considered symptomatic, including drug therapy and surgical therapies such as deep brain stimulation [1].
In Japan, there were 135,152 holders of medical subsidy certificates for fiscal year 2019 (Reiwa 1). This is the number of certificate holders, not the total number of patients. Onset is most common between ages 50 and 65, and onset before age 40 is classified as young-onset [1].
Although it is a progressive disease, the life prognosis is not poor, and average life expectancy is said to be only 2 to 3 years shorter than the general population [1].
5. How Much Do Scientists Know About Why Cues Help People with Parkinson’s Disease Move?
Dopamine is decreasing, yet people can move when given a cue. The mechanism behind this phenomenon is still at the hypothesis stage.
One theory is that the brain circuits handling motivation and emotion (the limbic system) may influence movement speed. Because movement speed changes with motivation, it has been suggested that the limbic system may interact with the parts of the brain that control movement [5]. However, this is not a confirmed mechanism.
The fact that the ability to move is temporary is also an important characteristic of this phenomenon.
6. How Can You Investigate Floor-Line Cues Yourself in a Hallway?
What you can do today: In a wide hallway with no people, check your usual stride length over 3 steps. Place tape across the walking direction at each footprint position to make markers. Write down whether the ease of stepping changes when walking normally versus stepping over the tape. Note that this is a record of sensations in healthy people and does not reproduce the experience of those with the disease. Do this in a place with no people around, wearing non-slip shoes.
If you want to read more: The NCGM page on "Parkinson’s Disease" offers official explanations of symptoms and treatments. An explanatory paper on the 1817 essay is available in English on SciELO.